Pfizer announces COVID-19 vaccine by end of November
President Trump has been instrumental in getting the FDA to authorize an Emergency Use Authorization (EUA) should Pfizer come up with a safe vaccine for COVID-19. The company announced Monday, they believe they have one that is 90 percent effective in preventing COVID-19 and no serious safety concerns have been observed. Because of the EUA, once the safety milestone is achieved, Pfizer believes this will occur in the third week of November.
“Today is a great day for science and humanity. The first set of results from our Phase 3 COVID-19 vaccine trial provides the initial evidence of our vaccine’s ability to prevent COVID-19,” said Dr. Albert Bourla, Pfizer Chairman and CEO. “With today’s news, we are a significant step closer to providing people around the world with a much-needed breakthrough to help bring an end to this global health crisis. We look forward to sharing additional efficacy and safety data generated from thousands of participants in the coming weeks.”